Inventor · disambiguated record
Dean Y. Maeda
Also filed as: MAEDA DEAN · MAEDA DEAN Y
17 granted patents·2 pending applications·108 citations·filing 2001–2019
93Inventor score
Top patents by PatentIndex Score
19 records- 0194US8981106B2Pyrimidinecarboxamides as CXCR2 modulatorsSYNTRIX BIOSYSTEMS INC·Filed 2014·Granted Mar 17, 2015·9 cites·5 claims
- 0293US9707248B2Use of thiopyrimidinecarboxamide for treating cancerSYNTRIX BIOSYSTEMS INC·Filed 2016·Granted Jul 18, 2017·5 cites·24 claims
- 0393US9480694B2Thiopyrimidinecarboxamide for use in treating pulmonary diseaseSYNTRIX BIOSYSTEMS INC·Filed 2015·Granted Nov 1, 2016·6 cites·20 claims
- 0493US8969365B2Thiopyrimidinecarboxamides as CXCR1/2 modulatorsSYNTRIX BIOSYSTEMS INC·Filed 2013·Granted Mar 3, 2015·9 cites·17 claims
- 0593US8748623B2Pyridinecarboxamides as CXCR2 modulatorsMAEDA DEAN Y·Filed 2010·Granted Jun 10, 2014·15 cites·16 claims
- 0691US10046002B2Method for treating cancer using chemokine antagonistsSYNTRIX BIOSYSTEMS INC·Filed 2016·Granted Aug 14, 2018·6 cites·22 claims
- 0789US7176310B1Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agentsUCB SA·Filed 2003·Granted Feb 13, 2007·29 cites·11 claims
- 0888USRE47267EPyridinecarboxamides as CXCR2 modulatorsSYNTRIX BIOSYSTEMS INC·Filed 2016·Granted Mar 5, 2019·3 cites·80 claims
- 0988US8993541B2Aminopyrimidinecarboxamides as CXCR2 modulatorsSYNTRIX BIOSYSTEMS INC·Filed 2014·Granted Mar 31, 2015·9 cites·6 claims
- 1087US10130645B2Use of thiopyrimidinecarboxamide for treating cancerSYNTRIX BIOSYSTEMS INC·Filed 2017·Granted Nov 20, 2018·3 cites·20 claims
- 1186US8779149B2Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulatorsMAEDA DEAN Y·Filed 2011·Granted Jul 15, 2014·9 cites·6 claims
- 1285US10660909B2Method for treating cancer using chemokine antagonistsSYNTRIX BIOSYSTEMS INC·Filed 2018·Granted May 26, 2020·2 cites·29 claims
- 1382US10993953B2Method for treating cancer using chemokine antagonistsSYNTRIX BIOSYSTEMS INC·Filed 2019·Granted May 4, 2021·1 cites·31 claims
- 1466USRE48547EAminopyrimidinecarboxamides as CXCR2 modulatorsSYNTRIX BIOSYSTEMS INC·Filed 2017·Granted May 11, 2021·0 cites·40 claims
- 1563USRE47415EPyrimidinecarboxamides as CXCR2 modulatorsSYNTRIX BIOSYSTEMS INC·Filed 2017·Granted Jun 4, 2019·0 cites·62 claims
- 1661US8349837B2Pharmaceutical composition comprising racemic aminopterinAMINOPTERIN LLC·Filed 2010·Granted Jan 8, 2013·2 cites·18 claims
- 1755USRE47740EAminopyridinecarboxamides as CXCR2 modulatorsSYNTRIX BIOSYSTEMS INC·Filed 2016·Granted Nov 26, 2019·0 cites·27 claims
- 1848US2005004038A1Bivalent inhibitors of Glutathione-S-TransferasesFiled 2004·Application pending·0 cites
- 1939US2003212051A1Bile acid containing prodrugs with enhanced bioavailabiltyFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dean Y. Maeda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →